Laboratorios RichmondC.I.F (BASE:RICHD) - Stock Price, News & Analysis

RICHD Stock Overview

A pharmaceutical company, develops and manufactures pharmaceutical products.

RICHD fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Debt is not well covered by operating cash flow

Shares are highly illiquid

Does not have a meaningful market cap ($74B)

Large one-off items impacting financial results

Laboratorios Richmond S.A.C.I.F. Competitors

Instituto Rosenbusch

BASE:ROSE

AR$4.2b

Unité de Fabrication des Médicaments

BVMT:UMED

د.ت232.0m

Cuu Long Pharmaceutical

HOSE:DCL

₫1.9t

Accent Microcell

NSEI:ACCENTMIC

₹5.9b

Price History & Performance

Summary of all time highs, changes and price drops for Laboratorios RichmondC.I.F
Historical stock prices
Current Share Price	AR$0.75
52 Week High	AR$0.75
52 Week Low	AR$0.75
Beta	0.23
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	RICHD	AR Pharmaceuticals	AR Market
7D	0%	0.3%	1.6%
1Y	n/a	-9.6%	150.7%

Return vs Industry: Insufficient data to determine how RICHD performed against the AR Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how RICHD performed against the AR Market.

Price Volatility

Is RICHD's price volatile compared to industry and market?
RICHD volatility
RICHD Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.2%
Market Average Movement	6.9%
10% most volatile stocks in AR Market	8.5%
10% least volatile stocks in AR Market	5.0%

Stable Share Price: RICHD's share price has been volatile over the past 3 months compared to the AR market.

Volatility Over Time: Insufficient data to determine RICHD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1935	620	Juan Manuel Artola	www.richmondlab.com

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East.

Laboratorios Richmond S.A.C.I.F. Fundamentals Summary

How do Laboratorios RichmondC.I.F's earnings and revenue compare to its market cap?
RICHD fundamental statistics
Market cap	US$76.16m
Earnings (TTM)	US$3.66m
Revenue (TTM)	US$36.64m

20.8x

P/E Ratio

2.1x

P/S Ratio

Is RICHD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RICHD income statement (TTM)
Revenue	AR$35.58b
Cost of Revenue	AR$16.04b
Gross Profit	AR$19.54b
Other Expenses	AR$15.99b
Earnings	AR$3.55b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	43.99
Gross Margin	54.91%
Net Profit Margin	9.98%
Debt/Equity Ratio	221.5%

How did RICHD perform over the long term?

See historical performance and comparison

Laboratorios RichmondC.I.F BASE:RICHD Stock Report